Skip to main content
Fig. 9 | Journal of Translational Medicine

Fig. 9

From: CD58 acts as a tumor promotor in hepatocellular carcinoma via activating the AKT/GSK-3β/β-catenin pathway

Fig. 9

sCD58 activates the AKT/GSK-3β/β-Catenin pathway in HCC cells. a Representative western blotting results of AKT/GSK-3β/β-catenin pathway-related proteins (n = 3). b Immunofluorescence analysis of the localization of active β-catenin. c Subcellular fractionation analysis of the expression of total and active β-catenin in the nuclear and cytoplasmic fractions (n = 2)

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us